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Abstract
Air pollution by diesel exhaust particles is associated with elevated mortality and increased hospital admissions in
individuals with respiratory diseases such as asthma and chronic obstructive pulmonary disease. During active inflammation
monocytes are recruited to the airways and can replace resident alveolar macrophages. We therefore investigated whether
chronic fourteen day exposure to low concentrations of diesel exhaust particles can alter the phenotype and function of
monocytes from healthy individuals and those with chronic obstructive pulmonary disease. Monocytes were purified from
the blood of healthy individuals and people with a diagnosis of chronic obstructive pulmonary disease. Monocyte-derived
macrophages were generated in the presence or absence of diesel exhaust particles and their phenotypes studied through
investigation of their lifespan, cytokine generation in response to Toll like receptor agonists and heat killed bacteria, and
expression of surface markers. Chronic fourteen day exposure of monocyte-derived macrophages to concentrations of
diesel exhaust particles .10 mg/ml caused mitochondrial and lysosomal dysfunction, and a gradual loss of cells over time
both in healthy and chronic obstructive pulmonary disease individuals. Chronic exposure to lower concentrations of diesel
exhaust particles impaired CXCL8 cytokine responses to lipopolysaccharide and heat killed E. coli, and this phenotype was
associated with a reduction in CD14 and CD11b expression. Chronic diesel exhaust particle exposure may therefore alter
both numbers and function of lung macrophages differentiating from locally recruited monocytes in the lungs of healthy
people and patients with chronic obstructive pulmonary disease.
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Introduction
Inhalation of small particulate matter is a major cause of
airway inflammation, and rising air pollution levels are
associated with elevated mortality and increased hospital
admissions in individuals with respiratory diseases such as
asthma and chronic obstructive pulmonary disease (COPD)
[1,2,3]. Diesel Exhaust Particles (DEP) are a major particulate
matter of air pollution. Acute and chronic inhalation of DEP in
healthy individuals, and those with pre-existing respiratory
disease, results in respiratory toxicity with consequent develop-
ment of lung oedema, infiltration of polymorphonuclear
leukocytes, and the production of proinflammatory cytokines
and reactive oxygen species (ROS) [4,5,6,7]. Consequently these
can lead to deterioration of pre-existing respiratory disease [8]
and development of symptoms [9].
The adverse effects of DEP on alveolar macrophages (AMs)
have been extensively studied [10,11]. AMs represent one of the
first lines of defence against environmental and pathogenic stimuli,
and have lower functional responsiveness to environmental
particles compared to monocytes [12]. AMs are heavily implicated
in the pathogenesis of COPD [13] and are key players in
orchestrating the inflammatory response. The active inflammation
that occurs in asthma and COPD leads to the recruitment of
circulating monocytes to the alveolar wall, with the subsequent
replacement of resident AMs [14]. In addition, exposure to
particulate matter has been shown to cause the release of
monocytes from the bone marrow [15,16]. We have demonstrated
that monocytes avidly phagocytose DEP (Figures S1 and S2),
however, there are no studies to date investigating the chronic
effects of DEP on monocytes from individuals with COPD and
their subsequent fate and activation.
The existence of chronic inflammation as is observed in
individuals with COPD may alter the functional responses of
these cells to varied stimuli. Indeed, alveolar macrophages from
COPD individuals show reduced phagocytosis of apoptotic
epithelial cells compared to non smokers [17] and monocyte
derived macrophages (MDMs) from people with COPD also show
reduced phagocytosis in response to pathogens [18]. These
findings could have major implications for airway responses to
inhaled pathogens and the subsequent development of chronic
inflammation [19].
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We therefore investigated whether MDMs differentiated in the
presence or absence of DEP, from normal donors and people with
COPD, showed alterations in their phenotype and function that
might have implications for the pathology of particulate-induced
airways disease.
Materials and Methods
Materials
Reagents were purchased from Sigma-Aldrich (Poole, UK) or
Invitrogen (Paisley, UK), except where specified. National Institute
of Standards and Technology Diesel Exhaust Particles were used
(NIST DEP SRM 2975).
Table 1. Patient Demographics.
Healthy n=7 COPD n=8
Sex (Male/Female) 4/3 5/3
Age (years) 66 (44–69) 62 (51–68)
FEV1 (L) 3.14 (2.45–4.36) 1.77 (1.38–2.97)
FEV1 predicted (%) 101 (91–126) 68 (57–81)
FEV1/FVC % 78 (70–81) 63 (34–84)
Pack year history 0 26 (13–60)
Inhaled corticosteroid use (%) 0 50
Current smokers (%) 0 50
doi:10.1371/journal.pone.0051107.t001
Figure 1. DEP induced cell loss of MDMs from healthy volunteers. MDMs were differentiated from purified monocytes obtained from healthy
volunteers in the presence or absence of varied concentrations of DEP as described in the methods. A control well of MDMs were incubated
overnight in 1 mM staurosporine (ST). MDMs were visualised by microscopy at the stated time points. A total of 4 randomly selected
106magnification fields were visualised and cell counts were performed and denoted as total cell count. Data shown are mean6SEM of n = 6 for
panels A and B and n= 4 for C and D, performed on different donors. Significant differences in A and B are denoted by *p,0.05, **p,0.01 and
***p,0.001, compared to MDMs differentiated in the absence of DEP, as measured by two way ANOVA and Bonferroni’s post test. To facilitate
comparison the percentage cell loss was calculated compared to MDMs differentiated in the absence of DEP (C and D).
doi:10.1371/journal.pone.0051107.g001
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Monocyte Preparation
All studies involving healthy human volunteers were approved
by the Sheffield Research Ethics Committee and authorised and
sponsored by Sheffield Teaching Hospitals NHS Foundation
Trust (protocol STH15395, Sheffield Research Ethics Committee
Ref 05/Q2305/4). Studies involving Stage II GOLD criteria
COPD and age matched controls were approved by the Northwest
Research Ethics Committee (protocol 10/H1016/25) and spon-
sored by the Medicines Evaluation Unit Ltd (protocol DS-10-01).
All studies required fully informed written consent in full
accordance with all the principles of the Declaration of Helsinki.
Initial investigations were performed on healthy volunteers as
proof of concept and then selected experiments were further
explored in individuals with Stage II GOLD criteria COPD and
age matched controls (Table 1). Peripheral blood mononuclear
cells (PBMCs) were separated from granulocytes by centrifugation
over density gradients using OptiPrep (Axis shield, Oslo, Norway)
as previously described [20]. Monocytes were further purified by
negative magnetic selection using the Monocyte Isolation Kit II
(Miltenyi Biotec, Bergisch Gladbach, Germany) to a purity of
approximately 9160.5% (mean6SEM) CD14+ cells.
Timelapse Microscopy
Purified monocytes from healthy volunteers, at 2.56106/ml,
were stimulated with 50 mg/ml DEP for 1 hour. During this time
cells were visualised using an Olympus IX/71 inverted microscope
and timelapse microscopy was performed using a Coolsnap HQ/
ICX285 monochrome camera capturing images every 30 seconds
over a period of 60 minutes.
Preparation of Monocyte-Derived Macrophages (MDM)
Monocytes were isolated and purified as described above. Cells
were serum starved for 1 hour in 12 well tissue culture plates at
250,000/well in RPMI 1640 with 1% penicillin G (100 units/ml)
and streptomycin (100 mg/ml). The media was then removed and
cells washed with phosphate buffered saline (PBS) to remove non-
adherent cells. The media was replaced with RPMI 1640 with
10% newborn calf serum and penicillin G (100 units/ml) and
streptomycin (100 mg/ml) (MDM media) with 50 ng/ml macro-
phage colony stimulating factor (M-CSF) (PeproTech EC Ltd,
London, UK). Cells were cultured for three to four days and the
media then replaced with MDM media without M-CSF. Cells
were cultured for a total of 14 days with cell washes and media
changes every three to four days, allowing differentiation of
monocytes into MDM. For MDM that were differentiated in the
presence of DEP (DEP-MDM), varied concentrations of DEP
were added to the cells at the onset of culturing and at each change
of media.
At the indicated time points MDMs and DEP-MDMs were
harvested by washing the cells in PBS and harvested by gently
scraping using a cell scraper.
Assessment of Cell Loss
At day 1, 7, and 14, MDMs and DEP-MDMs were washed
three times with PBS and the media replaced. 10 mMHoechst was
added to the wells and incubated in the dark for three minutes.
Cells were visualised using a fluorescence and phase contrast Leica
DM14000B inverted microscope. For healthy volunteers a total of
4 randomly selected 106magnification fields were visualised and
cell counts were performed in each field. This resulted in total cell
counts ranging from 500–1500. For studies of stage II/III GOLD
COPD and age matched controls, and a total of 4 randomly
selected 406magnification fields were visualised. This produced a
total cell count within the fields and allowed comparison of cells
counts between MDMs and DEP-MDMs.
Measurement of Loss of Inner Mitochondrial
Transmembrane Potential (Dym)
At day 3 and 14, MDMs and DEP-MDMs from healthy
volunteers were washed three times in PBS. Cells were stained
with 10 mM 5,59,6,69-tetrachloro-1,19,3,39-tetraethylbenzimidazo-
lycarbocyanine iodide (JC-1, Molecular Probes, Eugene, OR,
USA) in serum free RPMI 1640 for 30 minutes at 37uC. The cells
were harvested as described above and resuspended in ice cold
PBS. Loss of Dym was detected using a FACSCalibur flow
cytometer and was indicated by a decrease in red fluorescence (FL-
2). Data were quantified as percentage of cells showing loss of red
staining compared to control cells [21], analysed by FlowJo
software (Tree Star Inc., Ashland, OR, USA).
Measurement of Loss of Lysosomal Acidification
At day 3 and 14, MDMs and DEP-MDMs from healthy
volunteers were washed three times in PBS. Cells were stained
with 5 mM acridine orange (AO) in serum free RPMI 1640 for 30
minutes at 37uC. The cells were harvested as described above.
Loss of fluorescence was measured by flow cytometry and data
were quantified as percentage of cells showing loss of green
staining compared to control cells as described [21].
Treatment of MDMs with Varied TLR Agonists
MDMs and DEP-MDMs from healthy volunteers, individuals
with Stage II GOLD criteria COPD, and age matched controls
were stimulated at Day 14. At the time of stimulation cells were
washed three times in PBS, media was replaced and final volumes
in each well of a 12-well plate always totalled 1,000 ml during
experiments. Cells were stimulated with TLR agonists: 10 or
100 ng/ml LPS (E. coli serotype R515 from Alexis, Nottingham,
UK) (TLR4), 10 mg/ml Pam3CSK4 (TLR2) or 10 mg/ml
gardiquimod (Invivogen, Toulouse, France) (TLR7/8). Controls
were stimulated with 10 ng/ml TNFa. Stimulated cells were
incubated for 24 hours at 37uC and humidified 5% CO2. Cell-free
supernatants were prepared and stored at –80uC until cytokine
generation was determined.
Treatment of MDMs with E. coli
MDMs and DEP-MDMs from healthy volunteers, individuals
with Stage II GOLD criteria COPD, and age matched controls
were stimulated at Day 14 as described above. Cells were
stimulated with heat killed E. coli at a ratio of 100 heat killed
bacteria per cell for 24 hours at 37uC. Cell-free supernatants were
Figure 2. DEP induced cell loss of MDMs from COPD and age matched controls. MDMs were differentiated from purified monocytes
obtained from stage II GOLD criteria COPD and age matched controls in the presence or absence of varied concentrations of DEP as described in the
methods. A control well of MDMs was incubated overnight in 1 mM staurosporine (ST). MDMs were visualised by microscopy at the stated time
points. A total of 4 randomly selected 40 magnification fields were visualised and cell counts were performed and denoted as total cell count. Data
shown are mean6SEM of n = 4, performed on different donors with significant differences denoted by *p,0.05, **p,0.01 and ***p,0.001 compared
to MDMs differentiated in the absence of DEP, as measured by one way ANOVA and Dunnett’s post test. To facilitate comparison the percentage cell
loss was calculated compared to MDMs differentiated in the absence of DEP.
doi:10.1371/journal.pone.0051107.g002
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prepared and stored at –80uC until cytokine generation was
determined.
Enzyme Linked Immunosorbent Assay (ELISA)
Cell-free supernatants were prepared and stored at –80uC until
cytokine generation was determined by ELISA using matched
pairs of antibodies (R&D Systems, Abingdon, UK) at optimized
concentrations as previously described [22]. Absorbance was
measured at 450 nm using an MRX plate reader (Thermo
Labsystems, Vantaa, Finland) and Biolinx software version 2.20
(Biolinx, Frankfurt am Main, Germany). Samples were typically
diluted so that the optical density fell within the optimal portion of
a log-lin standard curve. Limits of detection (LD) for the ELISAs
were 31.25 pg/ml. Samples whose values were below the LD were
assigned the LD value for analysis.
Phagocytosis of Latex Beads
Red fluorescent carboxylate- modified latex beads with a mean
diameter of 2 mm (L3030, Sigma) were opsonised in 10% human
AB serum (serum isolated from healthy volunteers) with RPMI
1640 for 60 minutes at 37uC and then incubated at an MOI of 10
with washed MDM and DEP-MDMs from healthy volunteers for
4 hours to allow phagocytosis. To account for extracellular
binding, phagocytosis was inhibited by adding 5 mM cytochalasin
D to control samples for 30 minutes prior to adding beads. Cells
were washed three times in PBS and harvested as described
previously. Phagocytosis was determined using flow cytometry by
detecting an increase in fluorescence associated with internalised
beads. The median fluorescence intensity of samples containing
cytochalasin D was subtracted from samples exposed to beads in
the absence of cytochalasin D.
Cell Surface Marker Expression by Flow Cytometry
MDMs and DEP-MDMs from healthy volunteers were
harvested at day 3 and 14 as described. Cells were suspended in
MDM media, centrifuged at 1000 g for 3 minutes and resus-
pended in buffer (PBS, 0.25% bovine serum albumin, 10 mM
HEPES). The cells were incubated at room temperature for 10
minutes with 50 mg/ml murine IgG and then incubated with 1:10
PE-conjugated anti-human TLR2 (Clone TL2.1), TLR4 (Clone
HTA125), CD11b (Clone ICRF44), CD14 (Clone 61D3), HLA-
DR (Clone LN3), CD80 (B7-1) or CD86 (B7-2) antibody or their
relevant 1:10 PE-conjugated mouse IgG2a (TLR2 and TLR4),
IgG2b (HLA-DR and CD86) and IgG1 (CD14, CD11b and
CD80) isotype controls (eBioscience, San Diego, USA). Fluores-
cence was measured in the FL-2 channel of a FACSCalibur flow
cytometer. Ten thousand events were recorded and data analysis
was performed using FlowJo software (Tree Star Inc., Ashland,
OR, USA) and quantified as specific mean fluorescence.
Statistics
Data were analysed using GraphPad Prism v5 (GraphPad Inc,
San Diego, CA, USA). Data were compared using one-way or
Figure 3. MDMs differentiated in the presence of DEP showed
loss of mitochondrial membrane potential (DYm). MDMs were
differentiated from purified monocytes in the presence or absence of
varied concentrations of DEP as described in the methods. At day 14
MDMs and DEP-MDMs from healthy volunteers were washed three
times in PBS. Cells were stained with 10 mM JC-1 in serum free RPMI
1640 for 30 minutes at 37uC. The cells were harvested and resuspended
in ice cold PBS for analysis by flow cytometry. Loss of Dym was detected
using a FACSCalibur flow cytometer and was indicated by a decrease in
red fluorescence (FL-2). Viable MDMs were identified based on size and
granularity on the forward and side scatter plots and ten thousand
events were recorded. Data were presented as percentage of cells
showing loss of red staining compared to control cells (A) and geomean
fluorescence (B) and data analysis was performed using FlowJo
software. Figure C shows a representative histogram flow analysis plot
from one donor. Data shown are mean6SEM of n= 4–5, performed on
different donors with significant differences denoted by *p,0.05,
**p,0.01 and ***p,0.001, compared to MDMs differentiated in the
absence of DEP, as measured by one way ANOVA and Dunnett’s post
test.
doi:10.1371/journal.pone.0051107.g003
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two-way analysis of variance (ANOVA) with the appropriate post
tests with a statistically significant values of p,0.05.
Results
We have previously demonstrated the important role that
monocytes can play in the cooperative signalling with epithelial
cells in response to DEP and pathogenic stimuli [23]. In active
inflammation monocytes are recruited to the airways and can
replace resident alveolar macrophages [14]. We therefore inves-
tigated whether chronic low dose DEP exposure can alter
monocyte phenotype or function. Here we have shown that
monocytes interact with and phagocytose DEP and that chronic
DEP exposure has profound effects on monocyte functional status.
DEP Induces Significant Cell Loss of MDMs Over 14 Days
Differentiation
We first studied the interaction of monocytes with DEP by
examining the extent to which they phagocytosed these particles.
Although difficult to quantify, in previous unpublished work we
have found by light microscopy that after a period of 24 hour
exposure monocytes contain phagocytosed DEP within vacuoles.
We demonstrate here that over a 1 hour exposure, monocytes
avidly interact with DEP in their vicinity (Figure S1 and S2). Even
over this short time period, a majority of visible DEP are either
phagocytosed or bound to monocytes. We therefore sought to
determine how persistent interaction of monocytes with DEP
would alter their survival or function.
In healthy volunteers, compared to untreated cells, those
differentiated in the presence of DEP concentrations greater than
5 mg/ml demonstrated a marked, significant reduction in absolute
cell number over a period of 14 days (Figure 1). Similarly in
individuals with stage II/III GOLD criteria COPD and age
matched controls, higher concentrations of DEP caused a
reduction of absolute cell numbers reaching statistical significance
in age matched controls at 7 days (Figure 2). Monocytes from
individuals with COPD were more resistant to the effects of DEP
compared to age matched controls. 10 mg/ml of DEP had no
significant impact on cell numbers at day 7 in COPD individuals,
but in age-matched controls, the same dose of DEP caused
significant cell loss at this time point. Cell loss in cells from people
with COPD did not achieve statistically significant levels.
MDMs Differentiated in the Presence of DEP Cause Loss
of Mitochondrial Membrane Potential (DYm)
The significant cell loss observed over time with higher
concentrations of DEP led us to investigate the potential
mechanisms in healthy volunteers. We initially looked at inner
mitochondrial membrane permeabilisation, a feature associated
with mitochondrial dysfunction and cell death pathways including
apoptosis. Here we demonstrate that DEP concentrations of 3 and
10 mg/ml caused a loss of inner mitochondrial membrane
potential at day 14 (Figure 3). Similar changes were seen at
earlier time points (3 days), but at these earlier points when
Figure 4. MDMs differentiated in the presence of DEP showed
loss of lysosomal acidification. MDMs were differentiated from
purified monocytes in the presence or absence of varied concentrations
of DEP as described in the methods. At day 14 cells from healthy
volunteers were stained with 5 mM acridine orange (AO) for 30 minutes
at 37uC. The cells were harvested and resuspended in ice cold PBS for
analysis using a FACSCalibur flow cytometer. Loss of lysosomal
acidification was measured in the FL-3 channel. Viable MDMs were
identified based on size and granularity on the forward and side scatter
plots and ten thousand events were recorded. Data were presented as
percentage of cells showing loss of green staining compared to control
cells (A) and geomean fluorescence (B) and data analysis was performed
using FlowJo software. Figure C shows a representative histogram flow
analysis plot from one donor. Data shown are mean6SEM of n = 4–5,
performed on different donors with significant differences denoted by
*p,0.05, **p,0.01 and ***p,0.001, compared to MDMs differentiated
in the absence of DEP, as measured by one way ANOVA and Dunnett’s
post test.
doi:10.1371/journal.pone.0051107.g004
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macrophage differentiation was incomplete, cell fragility precluded
reliable recovery of cells for statistical analysis.
MDMs Differentiated in the Presence of DEP Cause Loss
of Lysosomal Acidification
We sought to ascertain whether monocyte uptake of DEP had
an effect on lysosomal function. Loss of lysosomal acidification was
detected using AO as described in the methods. Here we show in
healthy volunteers that higher concentrations of DEP at 10 mg/ml
cause loss of lysosomal acidification at day 14. Lower concentra-
tions of DEP (1 and 3 mg/ml) had no effect (Figure 4). Similar
changes were seen at earlier time points (3 days), but at these
earlier points when macrophage differentiation was incomplete,
cell fragility precluded reliable recovery of cells for statistical
analysis.
MDMs Differentiated in the Presence of DEP did not
Demonstrate Cytoplasmic Release of Cytochrome c or
Caspase Activation
Loss of inner mitochondrial membrane potential can result in
the release of cytochrome c into the cytoplasm and subsequent
activation of various caspases. Because we demonstrated a loss of
DYm with DEP differentiated cells we hypothesised that there
would be evidence of cytoplasmic release of cytochrome c and
subsequent caspase activation. However we found by western blot
analysis that this was not detected in the presence of DEP (data not
shown).
MDMs Differentiated in the Presence of DEP Showed
Reduced Responses to TLR Agonists
DEP exposure caused monocyte loss, and we also therefore
considered that DEP would alter monocyte function. We elected
Figure 5. MDMs from healthy volunteers differentiated in the presence of DEP showed reduced proinflammatory responses to LPS.
MDMs from healthy volunteers were differentiated from purified monocytes in the presence or absence of varied concentrations of DEP as described
in the methods. At day 14 MDMs were washed and stimulated with varied TLR agonists or TNFa as shown. After 24 hours, levels of CXCL8 in the
supernatant were determined by ELISA. Data shown are mean6SEM of n = 4, performed on different donors with significant differences denoted by
*p,0.05, **p,0.01 and ***p,0.001, compared to MDMs differentiated in the absence of DEP, as measured by two way ANOVA and Bonferroni’s post
test.
doi:10.1371/journal.pone.0051107.g005
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to study functional responses at concentrations of DEP not causing
significant cell loss to facilitate accurate comparisons between
groups. In healthy volunteers (Figure 5), or individuals with COPD
and their age matched controls (Figure 6), MDMs differentiated in
the presence of low concentrations of DEP produced markedly less
CXCL8 in response to LPS (TLR4) and gardiquimod (TLR7), but
similar levels in response to Pam3CSK4 (TLR2) and TNFa.
MDMs Differentiated in the Presence of DEP Showed
Reduced Responses to E. coli
The altered functional response of reduced cytokine release,
primarily to LPS, was further explored by stimulating cells from
healthy individuals, those with COPD and age matched controls
with heat killed bacteria E. coli. Similarly to the findings with LPS,
MDMs from all 3 groups differentiated in the presence of DEP
produced less CXCL8 in response to heat killed E. coli (Figure 7).
We observed in healthy volunteers that DEP exposure did not
alter phagocytosis of latex beads (data not shown).
MDMs Differentiated in the Presence of DEP Showed
Altered TLR4 Coreceptor Expression
Chronic DEP exposure may affect macrophage differentiation
and it was proposed that this reduction in CXCL8 response to
LPS and heat killed bacteria may be due to altered states of
differentiation. We examined the expression of 7 surface markers
by flow cytometry in healthy volunteers. At day 14 there was no
detectable surface CD80 expression and very low surface TLR2
and TLR4 expression that was unaltered in the presence of DEP
(data not shown). In contrast, CD14 was expressed at low levels
that were further reduced by DEP exposure, and CD11b and
CD86 were expressed at high levels that were modestly but
significantly reduced by DEP (Figure 8).
Figure 6. MDMs from COPD and age matched controls differentiated in the presence of DEP showed reduced proinflammatory
responses to LPS. MDMs from COPD and age matched controls were differentiated from purified monocytes in the presence or absence of varied
concentrations of DEP as described in the methods. At day 14 MDMs were washed and stimulated with 10 ng/ml LPS or 10 mg/ml PAM3CSK4. After 24
hours, levels of CXCL8 in the supernatant were determined by ELISA. Data shown are mean6SEM of n = 5, performed on different donors with
significant differences denoted by *p,0.05, **p,0.01 and ***p,0.001, compared to MDMs differentiated in the absence of DEP, as measured by one
way ANOVA and Dunnett’s post test.
doi:10.1371/journal.pone.0051107.g006
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Discussion
In this study we have identified additional effects that DEP
exposure may have on the function of monocytic phagocytes, with
potential consequences for pulmonary innate immunity. In
particular, we have shown that chronic treatment of cells with
DEP results in cellular toxicity with marked loss of cells in
prolonged culture. In addition chronic low dose diesel particulate
treatment that is at levels thought to be representative of
environmental pollution exposure impaired the proinflammatory
responses of monocyte-derived macrophages to pathogenic
stimuli.
Studies have demonstrated that alveolar macrophages and
MDMs from COPD individuals show reduced phagocytosis of
apoptotic epithelial cells [17] and reduced phagocytosis of
pathogens [18] respectively, compared to non smokers. Epithelial
cells from individuals with COPD show higher susceptibility to the
effects of cigarette smoke with the release of the proinflammatory
mediators IL-1b and ICAM-1, and reduction of antioxidant levels
[24]. The nasal epithelium of individuals with severe COPD also
have reduced TLR4 expression [19] and expression of IL-1
receptor antagonist (IL-1ra) [25], which could have major
implications for airway responses to inhaled pathogens and the
subsequent development of chronic inflammation [19]. In light of
these findings our aims were two fold. Firstly, to explore the
chronic effects of DEP exposure on monocyte phenotype and
function in normal healthy individuals. Secondly, to address the
hypothesis that MDMs from COPD individuals would have
altered responses to DEP.
As we show here, monocytes avidly interact with and
phagocytose DEP, and we have previously shown that monocytes
are important mediators of cooperative inflammatory responses
with epithelial cells in response to DEP [23]. In our studies in
healthy volunteers chronic exposure to higher concentrations of
DEP (.10 mg/ml) caused loss of lysosomal acidification and loss of
mitochondrial membrane polarisation, and was associated with a
gradual loss of cells over time both in healthy and COPD
individuals. We observed that chronic exposure to concentrations
of DEP that are generally perceived to be representative of low
level exposure can impair responses to pathogenic stimuli. Finally,
we demonstrate a reduction in cell surface expression of receptors
and molecules that are implicated in these responses. These data
demonstrate that the actions of chronic DEP exposure may impair
the maintenance of a stable macrophage environment in the lungs
of healthy and COPD individuals, with potentially important
consequences in inflammatory lung diseases and control of
pathogens.
Extrapolation of in vitro concentrations to in vivo exposure is
complicated by a number of physiological factors such as
variations in tidal breathing, body size, lung surface area and
clearance mechanisms. Using a complex in vivo dosimetric study Li
et al has equated a concentration range of 1–100 mg/ml to
pollution levels experienced over 24 hours in a California state
[26]. The majority of in vitro and in vivo studies exploring the
inflammatory effects of DEP utilise concentrations above 50 mg/
ml, with a dose dependent effect on varied cell types
[4,6,10,15,27,28,29,30]. We have observed here that lower
concentrations over longer time periods can have important
effects on monocyte function, potentially extending the dose range
at which DEP exposure may have important physiological effects,
and suggesting that chronicity of exposure may be important in
understanding pathological consequences.
The direct toxicity of DEP over short time courses in a variety of
cell types is well established [6,12,27,28,29,30]. Here we
Figure 7. MDMs from healthy volunteers differentiated in the
presence of DEP showed reduced proinflammatory responses
to E. coli. MDMs from healthy volunteers, COPD and age matched
controls were differentiated from purified monocytes in the presence or
absence of varied concentrations of DEP as described in the methods.
At day 14 MDMs were washed and stimulated with heat killed E. coli as
shown. After 24 hours, levels of CXCL8 in the supernatant were
determined by ELISA. Data shown are mean6SEM of n = 5, performed
on different donors with significant differences denoted by *p,0.05,
**p,0.01 and ***p,0.001, compared to MDMs differentiated in the
absence of DEP, as measured by one way ANOVA and Dunnett’s post
test.
doi:10.1371/journal.pone.0051107.g007
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demonstrate that chronic exposure over 14 days to concentrations
of DEP.5 mg/ml induced a marked loss of monocytes during
their differentiation to macrophages, from both healthy and
COPD individuals. Monocytes from people with COPD were
more resistant to DEP-induced loss, since cell loss did not achieve
statistical significance at the earlier time point and only achieved
significance with higher doses of DEP at later points. The
mechanisms underpinning this partial resistance to cell loss remain
to be determined, but may reflect some aspect of chronic
inflammatory conditioning of these cells. A limitation of our study
is that we only had one control group for people with COPD,
these being healthy age-matched non smokers. Thus we cannot be
clear as to whether the differences we have observed are a result of
smoking, COPD, or both processes. We observed that cell loss in
healthy individuals was associated with a loss of mitochondrial
membrane potential, a feature consistent with induction of
apoptosis. In human macrophages and macrophage cell lines
DEP has previously been shown to induce a concentration and
time dependent increase in apoptosis with mitochondrial dysfunc-
tion, though these studies used higher concentrations of DEP over
a shorter 10 hour time period [11]. We attempted to define
mechanisms of cell loss in more detail, measuring cytochrome c
release and caspase activation by western blotting. However, at
any time point of the assay the observed cell loss equated to a 2.9–
5.7% cells lost per day or 0.12–0.24% per hour. We were unable
to detect cytochrome c release and caspase activation in cells
chronically exposed to all concentrations of DEP, probably
consequent upon the small number of cells at any point executing
the final components of the cell death pathways. It may also be
that activation of these cell death pathways would also be rapidly
associated with detachment from the plate, and such non-adherent
cells would not be captured in our assays. We considered including
additional assays such as TUNEL to measure cell loss, but again
the very low hourly rate of cell death would make detecting
changes in cell death rates with this assay very challenging.
The marked loss of cells during differentiation with higher
concentrations of DEP led us to investigate the functional
consequences of DEP exposure. We studied cellular responses to
chronic exposure to low concentrations of DEP for two reasons,
firstly higher concentrations of DEP caused cell loss that would
confound our results and secondly we hypothesised that changes in
cell phenotype were likely to occur at concentrations of DEP less
than those inducing cell death. We found that MDMs from
healthy and COPD individuals differentiated in the presence of
low concentrations of DEP had reduced CXCL8 production in
response to the TLR4 agonist LPS and the synthetic TLR7/8
agonist gardiquimod, but not the TLR2 agonist PAM3CSK4 or
the cytokine TNFa. The phagocytosis of latex beads was preserved
and the same in MDMs and DEP-MDMs at day 14 suggesting
that the reduction in CXCL8 production in DEP-MDMs could
not be entirely explained by overload of the MDMs by DEP.
We also showed that monocytes avidly interact with and
phagocytose DEP, and this may result in lysosomal dysfunction.
Reduced responses to gardiquimod suggest that endosomal
signalling may be disrupted as a result of DEP uptake.
Interestingly, TLR4 signalling has components that are activated
at the cell membrane (via MyD88) and the endosome (via TRAM)
[31]. The preservation of TLR2 signalling and responses to TNFa
may suggest that responses at the cell membrane are relatively
preserved, and a feasible explanation for the reduction of
responses to LPS may be that a component of the TLR4 signal
from the endosome is impaired similarly to the loss of responses to
gardiquimod. Alternatively, disruption of endosomal function may
alter TLR4 localisation and trafficking, which are also important
considerations in the generation of an effective TLR4 response
[32]. A final mechanism potentially reducing TLR4 signalling is
loss of essential coreceptors such as CD14 [33] or CD11b [34].
Our data show a loss of cell surface CD14 and CD11b expression
in DEP-exposed monocytes. The relative contribution of each of
these pathways – altered signalling from the endosomal compart-
ment, altered TLR4 trafficking, or loss of coreceptors – in the
downregulation of TLR4 signalling is our current target for
exploration. Future work will also focus on the extension of work
to a more detailed characterisation on macrophage M1/M2
phenotypes, and whether DEP exposure changes the proportion of
cells showing wound healing vs proinflammatory phenotypes.
Consistent with our findings with LPS, we observe a reduction
of CXCL8 production in MDMs differentiated in the presence of
DEP in response to heat killed E. coli, a Gram negative bacteria,
that activates TLR4 signalling. In combination with evidence that
DEP alters macrophage responses to subsequent bacterial and
viral pathogen invasion [35,36], our data provide additional
potential explanations for the observed positive association
between living next to a heavily lorry-trafficked road and the
development of lower respiratory tract infection (LRTI), bronchi-
olitis and pneumonia [9].
We observed no differences between healthy age matched
controls and individuals with COPD in CXCL8 production in
response to TLR agonists or E. coli. These results contrast with
those of Culpitt et al [37] who found higher CXCL8 production in
AM from COPD individuals in response to cigarette smoke extract
and LPS, and Taylor et al [18] who showed that MDMs from
people with COPD exhibited reduced phagocytosis of pathogens.
This may be related to phenotypic differences in our group of
COPD individuals who had less severe COPD as measured by
FEV1 and fewer pack years of smoking history. It is also true that
not all monocytes adhere to plates and differentiate into
macrophages, thus it is always possible that subsets of monocytes
with different phenotypes have been selectively lost or captured,
though these methodological issues remain challenging to measure
and control for. Multiple interacting factors such as patient
characteristics, underling genetic variations and environmental
influences, and minor differences in experimental methodology
may therefore account for these variations.
In conclusion our data demonstrate that chronic exposure to
low concentrations of DEP exerts multiple detrimental effects on
infiltrating monocytes. DEP activates cell networks of monocytes
and epithelial cells encouraging the development of inflammation
and persistent monocyte recruitment to the airways [23]. Coupled
with this, significant death of recruited monocytes and release of
Figure 8. MDMs differentiated in the presence of DEP showed reduced CD14, CD11b and CD86 surface marker expression. MDMs
from healthy volunteers were differentiated from purified monocytes in the presence or absence of varied concentrations of DEP as described in the
methods. At day 14 MDMs were harvested and non specific binding was blocked by incubating at room temperature for 10 minutes with 1:50 IgG
from murine serum reagent grade in FACS buffer. Cells were then incubated with 1:10 PE conjugated mouse anti-human CD14, CD11b, HLA-DR, TLR2,
TLR4, CD80 or CD86 or the respective isotype controls. PE fluorescence was measured on the FL-2 channel of a FACSCalibur flow cytometer. Data are
presented as a mean6SEM of n = 4 performed on different donors and representative histogram flow analysis plots from one donor. Significant
differences between MDMs and DEP-MDMs cell surface expression are denoted by *p,0.05 and **p,0.01 as measured by one way ANOVA and
Dunnett’s post test.
doi:10.1371/journal.pone.0051107.g008
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toxic mediators could exacerbate and contribute to an already
inflamed tissue environment. In addition, disruption of endosomal
signalling and alterations of surface marker expression could
adversely affect the subsequent responses to pathogenic stimuli.
Thus chronic exposure to air pollution in the form of diesel
exhaust particles may exacerbate and perpetuate the development
chronic inflammation.
Supporting Information
Figures S1 Timelapse video: Monocytes rapidly phago-
cytose DEP. Purified monocytes were obtained and cultured at
2.56106/ml as described in the methods. Cells were incubated
with 50 mg/ml DEP and timelapse microscopy performed every
30 seconds for 60 minutes as described in the methods. Data
shown are representative images of n= 2, performed on different
donors.
(MPG)
Figures S2 Still images: Monocytes rapidly phagocytose
DEP. Methods are described as in Figure S1. Figure S2 are still
images of monocytes and DEP at time t = 0 minutes (A) and t = 60
minutes (B) of timelapse microscopy. Data shown are represen-
tative images of n = 2, performed on different donors.
(TIFF)
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